Simultaneous intrastriatal and intranigral fetal dopaminergic grafts in patients with Parkinson disease: a pilot study

Report of three cases

Restricted access

✓ The main neural transplantation strategy in Parkinson disease (PD) has been focused on reinnervating the striatum. The clinical results reported in patients who receive transplants have been limited and do not justify the use of neural transplantation as a routine therapeutic procedure for PD. Identifying the optimal target for transplantation may be one of the critical factors for optimizing clinical outcomes. Evidence from preclinical studies indicates that simultaneous intrastriatal and intranigral grafts (double grafts) may produce a more complete functional recovery. The authors report the clinical and positron emission tomography (PET) scanning results in three patients enrolled in a safety and feasibility pilot study who received double grafts and who have been followed for up to 13 months posttransplantation.

Patients included in the study had idiopathic PD. All patients underwent detailed assessments before and after surgery, in accordance with the Core Assessment Program for Intracerebral Transplantation. The patients received implants of fetal mesencephalic cell suspensions in the putamen and substantia nigra (SN) bilaterally. There were no intraoperative or perioperative complications. Follow-up PET scans demonstrated an increase in the mean fluorodopa uptake constant values in the putamen and SN 12 months postsurgery. Improvements were also noted in the total Unified Parkinson′s Disease Rating Scale, Hoehn and Yahr, Schwab and England, and pronation/supination scores after transplantation. The authors demonstrate the feasibility of reinnervating the SN and striatum by using a double transplant strategy in humans.

Article Information

Address reprint requests to: Ivar Mendez, M.D., Division of Neurosurgery, QEII Health Sciences Centre, New Halifax Infirmary, 1796 Summer Street, Room #3806, Halifax, Nova Scotia, Canada B3H 3A7. email: mendez@is.dal.ca.

© AANS, except where prohibited by US copyright law.

Headings

Figures

  • View in gallery

    Diagram illustrating the double transplant strategy. Four graft deposits are implanted into the putamen and one is implanted into the SN.

  • View in gallery

    Axial T2-weighted MR images obtained 24 hours postoperatively in a patient with PD who received simultaneous intrastriatal and intranigral fetal VM grafts. A: Axial MR image depicting four tracts of graft deposits into the right putamen (arrow). B: Axial MR image depicting a graft deposit into the right SN (arrow).

  • View in gallery

    Graphs showing the mean performance scores before and after surgery in the on and off state for total UPDRS, Hoehn and Yahr, and Schwab and England scores, and the timed motor task of pronation/supination for the right (R) and left hand (L). Error bars are marked with 95% confidence intervals. Overlapping error bars postoperatively indicate nonsignificant differences between the on and off states. n = number of patients; postop1, −2, and −3 = last three postoperative scores; preop1 and −2 = first and second preoperative scores.

  • View in gallery

    Preoperative and postoperative fluorodopa PET scans obtained in a patient with PD (Case 3) who received simultaneous intrastriatal and intranigral fetal VM grafts. These images consist of parametric maps of fluorodopa Ki transformed into stereotactic space and overlaid on the patient's MR image (also in stereotactic space). The parametric maps were smoothed using an 8-mm gaussian filter. The axial, coronal, and sagittal sections demonstrate an increase in Ki in the midbrain and putamen bilaterally, likely resulting from surviving grafted dopamine neurons.

References

  • 1.

    Apostolides CSanford EHong Met al: Glial cell line-derived neurotrophic factor improves intrastriatal graft survival of stored dopaminergic cells. Neuroscience 83:3633721998Apostolides C Sanford E Hong M et al: Glial cell line-derived neurotrophic factor improves intrastriatal graft survival of stored dopaminergic cells. Neuroscience 83:363–372 1998

  • 2.

    Baker KASadi DHong Met al: Simultaneous intrastriatal and intranigral dopaminergic grafts in the parkinsonian rat model: role of the intranigral graft. J Comp Neurol 426:1061162000Baker KA Sadi D Hong M et al: Simultaneous intrastriatal and intranigral dopaminergic grafts in the parkinsonian rat model: role of the intranigral graft. J Comp Neurol 426:106–116 2000

  • 3.

    Brundin PPogarell OHagell Pet al: Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease. Brain 123:138013902000Brundin P Pogarell O Hagell P et al: Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease. Brain 123:1380–1390 2000

  • 4.

    Cheramy ALeviel VGlowinski J: Dendritic release of dopamine in the substantia nigra. Nature 289:5375421981Cheramy A Leviel V Glowinski J: Dendritic release of dopamine in the substantia nigra. Nature 289:537–542 1981

  • 5.

    Cheramy ANieoullon AGlowinski J: In vivo evidence for a dendritic release of dopamine in cat substantia nigra. Appl Neurophysiol 42:57591979Cheramy A Nieoullon A Glowinski J: In vivo evidence for a dendritic release of dopamine in cat substantia nigra. Appl Neurophysiol 42:57–59 1979

  • 6.

    Collins DLNeelin PPeters TMet al: Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space. J Comput Assist Tomogr 18:1922051994Collins DL Neelin P Peters TM et al: Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space. J Comput Assist Tomogr 18:192–205 1994

  • 7.

    Cytel Software Corporation: StateXact 4 for Windows. Statistical Software for Exact Nonparametric Inference. User Manual. Cambridge, MA: Cytel Software1999Cytel Software Corporation: StateXact 4 for Windows. Statistical Software for Exact Nonparametric Inference. User Manual. Cambridge MA: Cytel Software 1999

  • 8.

    Evans ACMarrett STorrescorzo Jet al: MRI-PET correlation in three dimensions using a volume-of-interest (VOI) atlas. J Cereb Blood Flow Metab 11:A69A781991Evans AC Marrett S Torrescorzo J et al: MRI-PET correlation in three dimensions using a volume-of-interest (VOI) atlas. J Cereb Blood Flow Metab 11:A69–A78 1991

  • 9.

    Fahn SElton RLMembers of the UPDRS Development Committee: Unified Parkinson's Disease Rating Scale in Fahn SMarsden CDGoldstein Met al (eds): Recent Developments in Parkinson's Diseaseed 2. New York: Macmillian1987 pp 153163pp 293–304Fahn S Elton RL Members of the UPDRS Development Committee: Unified Parkinson's Disease Rating Scale in Fahn S Marsden CD Goldstein M et al (eds): Recent Developments in Parkinson's Disease ed 2. New York: Macmillian 1987 pp 153–163 pp 293–304

  • 10.

    Freed CRBreeze RERosenberg NLet al: Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease. N Engl J Med 327:154915551992Freed CR Breeze RE Rosenberg NL et al: Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease. N Engl J Med 327:1549–1555 1992

  • 11.

    Freed CRGreene PEBreeze REet al: Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med 344:7107192001Freed CR Greene PE Breeze RE et al: Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med 344:710–719 2001

  • 12.

    Freeman TB: From transplants to gene therapy for Parkinson's disease. Exp Neurol 144:47501997Freeman TB: From transplants to gene therapy for Parkinson's disease. Exp Neurol 144:47–50 1997

  • 13.

    Freeman TBOlanow CWHauser RAet al: Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease. Ann Neurol 38:3793881995Freeman TB Olanow CW Hauser RA et al: Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease. Ann Neurol 38:379–388 1995

  • 14.

    Gauchy CKemel MLDesban Met al: The role of dopamine released from distal and proximal dendrites of nigrostriatal dopaminergic neurons in the control of GABA transmission in the thalamic nucleus ventralis medialis in the cat. Neuroscience 22:9359461987Gauchy C Kemel ML Desban M et al: The role of dopamine released from distal and proximal dendrites of nigrostriatal dopaminergic neurons in the control of GABA transmission in the thalamic nucleus ventralis medialis in the cat. Neuroscience 22:935–946 1987

  • 15.

    Hagell PSchrag APiccini Pet al: Sequential bilateral transplantation in Parkinson's disease: effects of the second graft. Brain 122:112111321999Hagell P Schrag A Piccini P et al: Sequential bilateral transplantation in Parkinson's disease: effects of the second graft. Brain 122:1121–1132 1999

  • 16.

    Hauser RAFreeman TBSnow BJet al: Long-term evaluation of bilateral fetal nigral transplantation in Parkinson disease. Arch Neurol 56:1791871999Hauser RA Freeman TB Snow BJ et al: Long-term evaluation of bilateral fetal nigral transplantation in Parkinson disease. Arch Neurol 56:179–187 1999

  • 17.

    Hoehn MMYahr MD: Parkinsonism: onset, progression and mortality. Neurology 17:4274421967Hoehn MM Yahr MD: Parkinsonism: onset progression and mortality. Neurology 17:427–442 1967

  • 18.

    Jackson EAKelly PH: Role of nigral dopamine in amphetamine-induced locomotor activity. Brain Res 278:3663691983Jackson EA Kelly PH: Role of nigral dopamine in amphetamine-induced locomotor activity. Brain Res 278:366–369 1983

  • 19.

    Kordower JHFreeman TBOlanow CW: Neuropathology of fetal nigral grafts in patients with Parkinson's disease. Mov Disord 13 (Suppl 1):88951998Kordower JH Freeman TB Olanow CW: Neuropathology of fetal nigral grafts in patients with Parkinson's disease. Mov Disord 13 (Suppl 1):88–95 1998

  • 20.

    Kordower JHFreeman TBSnow BJet al: Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N Engl J Med 332:111811241995Kordower JH Freeman TB Snow BJ et al: Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N Engl J Med 332:1118–1124 1995

  • 21.

    Langston JWWidner HGoetz CGet al: Core assessment program for intracerebral transplantations (CAPIT). Move Disord 7:2131992Langston JW Widner H Goetz CG et al: Core assessment program for intracerebral transplantations (CAPIT). Move Disord 7:2–13 1992

  • 22.

    Leenders KLSalmon EPTyrrell Pet al: The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson's disease. Arch Neurol 47:129012981990Leenders KL Salmon EP Tyrrell P et al: The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson's disease. Arch Neurol 47:1290–1298 1990

  • 23.

    Lindvall O: Neural transplantation: can we improve the symptomatic relief? Adv Neurol 80:6356401999Lindvall O: Neural transplantation: can we improve the symptomatic relief? Adv Neurol 80:635–640 1999

  • 24.

    Lindvall OBrundin PWidner Het al: Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 247:5745771990Lindvall O Brundin P Widner H et al: Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 247:574–577 1990

  • 25.

    Lindvall OSawle GWidner Het al: Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease. Ann Neurol 35:1721801994Lindvall O Sawle G Widner H et al: Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease. Ann Neurol 35:172–180 1994

  • 26.

    Mehta VHong MSpears Jet al: Enhancement of graft survival and sensorimotor behavioral recovery in rats undergoing transplantation with dopaminergic cells exposed to glial cell line-derived neurotrophic factor. J Neurosurg 88:108810951998Mehta V Hong M Spears J et al: Enhancement of graft survival and sensorimotor behavioral recovery in rats undergoing transplantation with dopaminergic cells exposed to glial cell line-derived neurotrophic factor. J Neurosurg 88:1088–1095 1998

  • 27.

    Mehta VSpears JMendez I: Neural transplantation in Parkinson's disease. Can J Neurol Sci 24:2923011997Mehta V Spears J Mendez I: Neural transplantation in Parkinson's disease. Can J Neurol Sci 24:292–301 1997

  • 28.

    Mendez IBaker KAHong M: Simultaneous intrastriatal and intranigral grafting (double grafts) in the rat model of Parkinson's disease. Brain Res Brain Res Rev 32:3283392000Mendez I Baker KA Hong M: Simultaneous intrastriatal and intranigral grafting (double grafts) in the rat model of Parkinson's disease. Brain Res Brain Res Rev 32:328–339 2000

  • 29.

    Mendez IDagher AHongMet al: Enhancement of survival of stored dopaminergic cells and promotion of graft survival by exposure of human fetal nigral tissue to glial cell line—derived neurotrophic factor in patients with Parkinson's disease. J Neurosurg 92:8638692000Mendez I Dagher A Hong M et al: Enhancement of survival of stored dopaminergic cells and promotion of graft survival by exposure of human fetal nigral tissue to glial cell line—derived neurotrophic factor in patients with Parkinson's disease. J Neurosurg 92:863–869 2000

  • 30.

    Mendez IHong M: Reconstruction of the striato-nigro-striatal circuitry by simultaneous double dopaminergic grafts: a tracer study using fluorogold and horseradish peroxidase. Brain Res 778:1942051997Mendez I Hong M: Reconstruction of the striato-nigro-striatal circuitry by simultaneous double dopaminergic grafts: a tracer study using fluorogold and horseradish peroxidase. Brain Res 778:194–205 1997

  • 31.

    Mendez IHong MSmith Set al: Neural transplantation cannula and microinjector system: experimental and clinical experience. Technical note. J Neurosurg 92:4934992000Mendez I Hong M Smith S et al: Neural transplantation cannula and microinjector system: experimental and clinical experience. Technical note. J Neurosurg 92:493–499 2000

  • 32.

    Mendez ISadi DHong M: Reconstruction of the nigrostriatal pathway by simultaneous intrastriatal and intranigral dopaminergic transplants. J Neurosci 16:721672271996Mendez I Sadi D Hong M: Reconstruction of the nigrostriatal pathway by simultaneous intrastriatal and intranigral dopaminergic transplants. J Neurosci 16:7216–7227 1996

  • 33.

    Nikkhah GBentlage CCunningham MGet al: Intranigral fetal dopamine grafts induce behavioral compensation in the rat Parkinson model. J Neurosci 14:344934611994Nikkhah G Bentlage C Cunningham MG et al: Intranigral fetal dopamine grafts induce behavioral compensation in the rat Parkinson model. J Neurosci 14:3449–3461 1994

  • 34.

    Olanow CWKordower JHFreeman TB: Fetal nigral transplantation as a therapy for Parkinson's disease. Trends Neurosci 19:1021091996Olanow CW Kordower JH Freeman TB: Fetal nigral transplantation as a therapy for Parkinson's disease. Trends Neurosci 19:102–109 1996

  • 35.

    Olsson MNikkhah GBentlage Cet al: Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test. J Neurosci 15:386338751995Olsson M Nikkhah G Bentlage C et al: Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test. J Neurosci 15:3863–3875 1995

  • 36.

    Patlak CSBlasberg RG: Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations. J Cereb Blood Flow Metab 5:5845901985Patlak CS Blasberg RG: Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations. J Cereb Blood Flow Metab 5:584–590 1985

  • 37.

    Peschanski MDefer GN'Guyen JPet al: Bilateral motor improvement and alteration of L-dopa effect in two patients with Parkinson's disease following intrastriatal transplantation of foetal ventral mesencephalon. Brain 117:4874991994Peschanski M Defer G N'Guyen JP et al: Bilateral motor improvement and alteration of L-dopa effect in two patients with Parkinson's disease following intrastriatal transplantation of foetal ventral mesencephalon. Brain 117:487–499 1994

  • 38.

    Piccini PBrooke DJBjorklund Aet al: Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient. Nat Neurosci 2:113711401999Piccini P Brooke DJ Bjorklund A et al: Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient. Nat Neurosci 2:1137–1140 1999

  • 39.

    Robertson GSRobertson HA: Evidence that L-dopa-induced rotational behavior is dependent on both striatal and nigral mechanisms. J Neurosci 9:332633311989Robertson GS Robertson HA: Evidence that L-dopa-induced rotational behavior is dependent on both striatal and nigral mechanisms. J Neurosci 9:3326–3331 1989

  • 40.

    Robertson HA: Dopamine receptor interactions: some implications for the treatment of Parkinson's disease. Trends Neurosci 15:2012061992Robertson HA: Dopamine receptor interactions: some implications for the treatment of Parkinson's disease. Trends Neurosci 15:201–206 1992

  • 41.

    Schwab REngland AC Jr: Projection technique for evaluating surgery in Parkinson's disease in Gillingham FJDonaldson IML (eds): Third Symposium on Parkinson's Disease. Edinburgh: E & S Livingstone1969 pp 152157Schwab R England AC Jr: Projection technique for evaluating surgery in Parkinson's disease in Gillingham FJ Donaldson IML (eds): Third Symposium on Parkinson's Disease. Edinburgh: E & S Livingstone 1969 pp 152–157

  • 42.

    Starr PAWichmann Tvan Horne Cet al: Intranigral transplantation of fetal substantia nigra allograft in the hemiparkinsonian rhesus monkey. Cell Transplant 8:37451999Starr PA Wichmann T van Horne C et al: Intranigral transplantation of fetal substantia nigra allograft in the hemiparkinsonian rhesus monkey. Cell Transplant 8:37–45 1999

  • 43.

    Vingerhoets FJGSchulzer MSnow BJ: Reproducibility of the fluorodopa positron emission tomography indices in Parkinson's disease. Mov Disord 9 (Suppl 1):1191994 (Abstract)Vingerhoets FJG Schulzer M Snow BJ: Reproducibility of the fluorodopa positron emission tomography indices in Parkinson's disease. Mov Disord 9 (Suppl 1):119 1994 (Abstract)

  • 44.

    Widner HTetrud JRehncrona Set al: Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. N Engl J Med 327:155615631992Widner H Tetrud J Rehncrona S et al: Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1236-tetrahydropyridine. N Engl J Med 327:1556–1563 1992

  • 45.

    Winkler CBentlage CNikkhah Get al: Intranigral transplants of GABA-rich striatal tissue induce behavioral recovery in the rat Parkinson model and promote the effects obtained by intrastriatal dopaminergic transplants. Exp Neurol 155:1651861999Winkler C Bentlage C Nikkhah G et al: Intranigral transplants of GABA-rich striatal tissue induce behavioral recovery in the rat Parkinson model and promote the effects obtained by intrastriatal dopaminergic transplants. Exp Neurol 155:165–186 1999

  • 46.

    Yurek DM: Intranigral transplants of fetal ventral mesencephalic tissue attenuate D1-agonist-induced rotational behavior. Exp Neurol 143:191997Yurek DM: Intranigral transplants of fetal ventral mesencephalic tissue attenuate D1-agonist-induced rotational behavior. Exp Neurol 143:1–9 1997

TrendMD

Cited By

Metrics

Metrics

All Time Past Year Past 30 Days
Abstract Views 324 324 91
Full Text Views 167 167 10
PDF Downloads 32 32 1
EPUB Downloads 0 0 0

PubMed

Google Scholar